Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Brachial Artery Access as a Novel Alternative for Impella 2.5 Insertion.

ABSTRACT: We describe a novel approach for percutaneous insertion of the Impella 2.5 (Abiomed Inc., Danvers, Massachusetts) through the brachial artery in 2 patients with inaccessible femoral arteries. Placement of the Impella 2.5 via the brachial artery was feasible and enabled the required hemodynamic support, with no procedural complications. (Level of Difficulty: Intermediate.).

SUBMITTER: Karami M

PROVIDER: S-EPMC8299254 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Brachial Artery Access as a Novel Alternative for Impella 2.5 Insertion.

Karami Mina M van Veelen Anna A Henriques José P S JPS

JACC. Case reports 20201021 12

We describe a novel approach for percutaneous insertion of the Impella 2.5 (Abiomed Inc., Danvers, Massachusetts) through the brachial artery in 2 patients with inaccessible femoral arteries. Placement of the Impella 2.5 via the brachial artery was feasible and enabled the required hemodynamic support, with no procedural complications. (<b>Level of Difficulty: Intermediate.</b>). ...[more]

PMID: 34317073

Similar Datasets

Left brachial artery: one more way to percutaneous insertion of IMPELLA 2.5L circulatory support for high-risk percutaneous coronary intervention - a case report.

Project description:BackgroundPercutaneous circulatory support allows the performance of coronary interventions in ever more complex anatomic and clinical situations. The large-bore systems currently available need a suitable vascular calibre to be inserted restricting percutaneous access mainly to the common femoral artery.Case summaryWe present the case of a 64-year-old man, admitted with an acute coronary syndrome and congestive heart failure, due to triple-vessel coronary artery disease with left main involvement and left ventricular dysfunction. He was successfully treated with percutaneous coronary intervention (PCI) supported through an IMPELLA 2.5L circulatory system. Concomitant severe and diffuse peripheral vascular disease did not allow femoral insertion of the circulatory support which was therefore successfully introduced through a left brachial percutaneous approach.DiscussionTo the best of our knowledge, this is the first report of a brachial, percutaneous placement of the IMPELLA 2.5L system to support a high-risk PCI procedure. In appropriately selected patients, this approach could be an option when common vascular accesses are not available.

| S-EPMC7793212 | biostudies-literature

Ultrasound guided pulmonary artery catheter insertion: An alternative to fluoroscopic guidance.

Project description:Pulmonary artery catheters (PACs) can provide extremely valuable objective data in select patients. They are usually advanced by floatation of balloon tip along the normal blood flow and their placement is confirmed under pressure waveform guidance. Imaging such as fluoroscopy is often employed in low flow states and in cardiac catheterization suite to reduce the failure rate and time to wedge; but is not readily available at bedside. In critically ill patient, bedside insertion is feasible but can be complicated by repeated attempts to float the balloon tip through various cardiac chambers. Point of care ultrasound can be used to visualize the balloon tip of PAC inside the cardiac chambers alongside the confirmatory pressure waveform changes.

| S-EPMC9151730 | biostudies-literature

Preclose Cinching "C-Stitch" to Aid Hemostasis After Impella Insertion.

Project description: Not available

| S-EPMC11307742 | biostudies-literature

Brachial artery transposition versus catheters as tertiary vascular access for maintenance hemodialysis: a single-center retrospective study.

Project description:Some hemodialysis patients are not suitable for creation of an arteriovenous fistula (AVF) or arteriovenous graft (AVG). However, they can receive a tunneled cuffed central venous catheter (tcCVC), but this carries risks of infection and mortality. We aimed to evaluate the safety and effectiveness of brachial artery transposition (BAT) versus those of tcCVC. This retrospective study evaluated hemodialysis patients who underwent BAT or tcCVC placement because of severe heart failure, hand ischemia, central venous stenosis or occlusion, inadequate vessels for creating standard arteriovenous access, or limited life expectancy. The primary outcome was whole access circuit patency. Thirty-eight patients who underwent BAT and 25 who underwent tcCVC placement were included. One-year patency rates for the whole access circuit were 84.6% and 44.9% in the BAT and tcCVC groups, respectively. The BAT group was more likely to maintain patency (unadjusted hazard ratio: 0.17, 95% confidence interval: 0.05-0.60, p = 0.006). The two groups did not have significantly different overall survival (log-rank p = 0.146), although severe complications were less common in the BAT group (3% vs. 28%, p = 0.005). Relative to tcCVC placement, BAT is safe and effective with acceptable patency in hemodialysis patients not suitable for AVF or AVG creation.

| S-EPMC8748867 | biostudies-literature

Novel interventional technique for the treatment of an iatrogenic pseudoaneurysm of the brachial artery.

Project description:This report presents the successful repair of an iatrogenic brachial artery pseudoaneurysm in a 72-year-old man who had peripheral artery disease and received endovascular treatment. A novel interventional method for treating iatrogenic femoral pseudoaneurysms with Perclose Proglide (Abbott Vascular Devices, Redwood City, CA, USA) has been reported; however, since a direct sheath insertion into the lumen of the pseudoaneurysm is initially required at the first step of this procedure, this strategy may prove limited in cases with small pseudoaneurysms. We describe the complete hemostasis of the pseudoaneurysm that was successfully achieved with endovascular treatment using the Perclose ProGlide suture-mediated closure system without using direct sheath insertion into the lumen of pseudoaneurysm. Our method may be effective in the repair of refractory pseudoaneurysms, in which direct sheath insertion is challenging. <Learning objective: To understand the potential risk and management of pseudoaneurysm which is associated with percutaneous catheterization. To understand the treatment options for pseudoaneurysm with endovascular method.>.

| S-EPMC9326010 | biostudies-literature

Usefulness of contrast computed tomography for diagnosing left ventricular thrombus before impella insertion.

Project description:The Impella (Abiomed, Danvers, MA, USA) is a novel percutaneous heart pump device for left ventricular (LV) assistance; however, LV thrombus is a notable contraindication for this device. Contrast computed tomography assessment is useful for detecting LV thrombus and preventing thromboembolism in patients recommended for Impella use. <Learning objective: The Impella (Abiomed, Danvers, MA, USA) is a heart pump device which aspirates blood from a left ventricular (LV) cavity and ejects it into an ascending aorta. Therefore, LV thrombus should be explored before the Impella insertion to prevent systemic embolism. Generally, echocardiography is the first choice to detect LV thrombus. Given limited diagnostic sensitivity for detecting LV thrombus in echocardiography, contrast computed tomography might be a useful strategy for the patient targeting Impella insertion.>.

| S-EPMC7718521 | biostudies-literature

Gene expression differences between the brachial and femoral artery of the Rapacz HC swine

Project description:The age groups were used to investigate how gene expression differences between the brachial and the femoral artery effect the heterogeneous atherosclerotic disease initiation and progression.

2011-12-31 | GSE21043 | GEO

Ankle- and Toe-Brachial Index for Peripheral Artery Disease Identification: Unlocking Clinical Data Through Novel Methods.

Project description:BackgroundDespite its high prevalence and clinical impact, research on peripheral artery disease (PAD) remains limited due to poor accuracy of billing codes. Ankle-brachial index (ABI) and toe-brachial index can be used to identify PAD patients with high accuracy within electronic health records.MethodsWe developed a novel natural language processing (NLP) algorithm for extracting ABI and toe-brachial index values and laterality (right or left) from ABI reports. A random sample of 800 reports from 94 Veterans Affairs facilities during 2015 to 2017 was selected and annotated by clinical experts. We trained the NLP system using random forest models and optimized it through sequential iterations of 10-fold cross-validation and error analysis on 600 test reports and evaluated its final performance on a separate set of 200 reports. We also assessed the accuracy of NLP-extracted ABI and toe-brachial index values for identifying patients with PAD in a separate cohort undergoing ABI testing.ResultsThe NLP system had an overall precision (positive predictive value) of 0.85, recall (sensitivity) of 0.93, and F1 measure (accuracy) of 0.89 to correctly identify ABI/toe-brachial index values and laterality. Among 261 patients with ABI testing (49% PAD), the NLP system achieved a positive predictive value of 92.3%, sensitivity of 83.1%, and specificity of 93.1% to identify PAD when compared with a structured chart review. The above findings were consistent in a range of sensitivity analysis.ConclusionsWe successfully developed and validated an NLP system for identifying patients with PAD within the Veterans Affairs electronic health record. Our findings have broad implications for PAD research and quality improvement.

| S-EPMC10807980 | biostudies-literature

Percutaneous thrombectomy of Impella-associated iliac artery thrombosis using the FlowTriever system.

Project description:Percutaneous thrombectomy using the FlowTriever system is a potentially safe and effective alternative to surgery in cases of Impella-associated peripheral arterial thrombosis.

| S-EPMC7752490 | biostudies-literature

Manual compression versus MANTA device for access management after impella removal on the ICU.

Project description:To compare the safety and efficacy of manual compression versus use of the MANTA closure device for access management after Impella removal on the intensive care unit (ICU). The number of patients treated with percutaneous left ventricular assist devices (pLVAD), namely Impella and ECMO, for complex cardiac procedures or shock, is growing. However, removal of pLVAD and large bore arteriotomy closure among such patients on the ICU remains challenging, since it is associated with a high risk for bleeding and vascular complications. Patients included in a prospective registry between 2017 and 2020 were analyzed. Bleeding and vascular access site complications were assessed and adjudicated according to VARC-2 criteria. We analyzed a cohort of 87 consecutive patients, who underwent access closure after Impella removal on ICU by using either the MANTA device or manual compression. The cohort´s mean age was 66.1 ± 10.7 years and 76 patients (87%) were recovering from CS. Mean support time was 40 h (interquartile range 24-69 h). MANTA was used in 31 patients (35.6%) and manual compression was applied in 56 patients (64.4%). Overall access related bleedings were significantly lower in the MANTA group (6.5% versus 39.3% (odds ratio (OR) 0.10, 95% CI 0.01-0.50; p = 0.001), and there was no significant difference in vascular complications between the two groups (p = 0.55). Our data suggests that the application of the MANTA device directly on the ICU is safe. In addition, it seems to reduce access related bleeding without increasing the risk of vascular complications.

| S-EPMC9388691 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data